Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hewlett Packard Enterprise CoHPE · Entity 2984 | Director | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hewlett Packard Enterprise Co
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,750 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Grant · Acquired 8,750 · Balance 8,750 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. |
| Common StockSEC Table I · non-derivative | Direct | 55,850 |
Reported balance
Holding disclosure · report date 2026-05-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 55,850 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
F2: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 12,396 · Balance 0 F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,022 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F3: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
ZYNGA INC
Report date May 23, 2022 · Filed May 24, 2022
Section 16 reporting ended · disclosed 2022-05-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-23 transaction · row 1
1 source rowRow 1 · 2022-05-23 · Disposition to issuer · Disposed 210,183 · Balance 0 F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations. F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations.
F2: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 5, 2026 21:07 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593861-26-000004 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 8,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:49 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 14,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593861-26-000002 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which cliff vested on the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.8406 dividend equivalent rights at $20.83 per RSU credited to the reporting person's account on 07/17/25, 80.5989 dividend equivalent rights at $22.96 per RSU credited to the reporting person's account on 10/17/25, 94.6123 dividend equivalent rights at $21.44 per RSU credited to the reporting person's account on 01/16/26 vested dividend equivalent rights, and a de minimis adjustment of 0.9482 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:49 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 14,500 | $23.98 | $347,710.00 |
DisclosureSEC source: 0001593861-26-000002 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2025 Filed May 6, 2025 21:10 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 14,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-25-008654 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,235 Underlying: Common Stock · 14,235 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 05/02/25, the reporting person was granted 14,235 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/02/26 or the date of Issuer's 2026 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:00 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 14,323 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-25-007105 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which cliff vested on 04/02/25, the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 reflects 88.4780 dividend equivalent rights at $20.67 per RSU credited to the reporting person's account on 07/18/24, 88.3925 dividend equivalent rights at $20.69 per RSU credited to the reporting person's account on 10/18/24, 78.1222 dividend equivalent rights at $23.41 per RSU credited to the reporting person's account on 01/16/25, 255 vested dividend equivalent rights, and a de minimus adjustment of 0.0073 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 21:00 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 14,323 | $16.12 | $230,886.76 |
DisclosureSEC source: 0001062993-25-007105 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2024 Filed May 14, 2024 21:11 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 14,068 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-010236 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,068 Underlying: Common Stock · 14,068 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 05/10/24, the reporting person was granted 14,068 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/10/25 or the date of Issuer's 2025 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 21:15 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 17,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-008357 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which cliff vested on 04/10/24, the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 120.9959 dividend equivalent rights at $16.87 per RSU credited to the reporting person's account on 07/14/23, 123.8592 dividend equivalent rights at $16.48 per RSU credited to the reporting person's account on 10/13/23, and 135.0825 dividend equivalent rights at $16.37 per RSU credited to the reporting person's account on 01/11/24. The number of derivative securities in column 5 reflects 380 dividend equivalent rights and a de minimus adjustment of 0.0624 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 21:15 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 17,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-008357 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2023 Filed May 9, 2023 21:04 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 17,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-010580 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,010 Underlying: Common Stock · 17,010 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 05/05/23, the reporting person was granted 17,010 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/05/24 or the date of Issuer's 2024 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| April 05, 2023 Filed Apr 8, 2023 01:02 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionRestricted Stock Units · Derivative | 9,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-008952 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights. F2 · price: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 09/22/22, the reporting person was granted 9,476 restricted stock units ("RSUs"), all of which cliff vested on 04/05/23, the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The number of derivative securities in column 5 includes 91.2616 dividend equivalent rights at $12.46 per RSU credited to the reporting person's account on 10/07/22, and 69.1258 dividend equivalent rights at $16.45 per RSU credited to the reporting person's account on 01/13/23. The number of derivative securities in column 5 also reflects 161 vested dividend equivalent rights and a de minimus adjustment of 0.6126 due to fractional rounding of the dividend equivalent rights. Read SEC document |
| April 05, 2023 Filed Apr 8, 2023 01:02 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | Exercise / conversionCommon Stock | 9,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-008952 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 20:45 UTC | Hewlett Packard Enterprise Co HPE · Entity 2984 | GrantRestricted Stock Units · Derivative | 9,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-019927 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,476 Underlying: Common Stock · 9,476 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · price: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.exercise_date: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. F2 · derivative.expiration_date: On 09/22/22, the reporting person was granted 9,476 Restricted Stock Units ("RSUs"), all of which will cliff vest on the earlier of 05/05/23 or the date of Issuer's 2023 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. Read SEC document |
| May 23, 2022 Filed May 24, 2022 17:00 UTC | ZYNGA INC ZNGA · Entity 126967 | Disposition to issuerClass A Common Stock | 210,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-031646 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The reported amount reflects certain non-reportable transfers from the Reporting Person to charitable organizations. F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of January 9, 2022 (the "Merger Agreement"), by and among Take-Two Interactive Software, Inc. ("Take-Two"), Zebra MS I, Inc., Zebra MS II, Inc., and the Issuer, each share of the Issuer's class A common stock was cancelled and converted into the right to receive (i) 0.0406 shares of Take-Two common stock and (ii) $3.50 in cash, together with cash in lieu of any fractional shares of Take-Two common stock. Read SEC document |
| May 17, 2022 Filed May 19, 2022 16:46 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 5,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030543 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,548 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 17, 2022 Filed May 19, 2022 16:46 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 5,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030543 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 18:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011885 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,548 Underlying: Class A Common Stock · 5,547 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 18:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011885 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 17:10 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065161 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,095 Underlying: Class A Common Stock · 5,547 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| November 17, 2021 Filed Nov 17, 2021 17:10 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065161 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 18:07 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052319 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,642 Underlying: Class A Common Stock · 5,547 shares Expires 2028-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 18:07 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 5,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052319 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| May 17, 2021 Filed May 19, 2021 19:10 UTC | ZYNGA INC ZNGA · Entity 126967 | GrantRestricted Stock Unit · Derivative | 22,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034193 · doc4.xml · derivative · entry 3 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,189 Underlying: Class A Common Stock · 22,189 shares Expires 2028-05-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F3 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 17, 2021, November 17, 2021, and February 17, 2022, and 25% of the restricted stock units vest on the earlier of May 17, 2022 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 19:10 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034193 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,219 shares Expires 2027-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 17, 2021 Filed May 19, 2021 19:10 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034193 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerRestricted Stock Units · Derivative | 1,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013930 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,022 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · price: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 20:04 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Disposition to issuerCommon Stock | 12,396 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-013930 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 19:30 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 8,950 | $10.59 | $94,780.50 |
DisclosureSEC source: 0001209191-21-025487 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,638 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.44 to $10.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:56 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 8,950 | $10.53 | $94,243.50 |
DisclosureSEC source: 0001209191-21-018330 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,588 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.22 to $11.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:14 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013019 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,219 Underlying: Class A Common Stock · 6,219 shares Expires 2027-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:14 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013019 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006379 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006379 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 08:51 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-005609 · form4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022 Underlying: Common Stock · 1,022 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 18:48 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 8,950 | $10.27 | $91,916.50 |
DisclosureSEC source: 0001209191-21-008295 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,319 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $10.17 to $10.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:09 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 8,950 | $9.79 | $87,620.50 |
DisclosureSEC source: 0001209191-21-001974 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,269 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020. F2 · price: The reported price in column 4 is a weighted average price (rounded to the nearest cent). These shares were sold in multiple transactions at prices ranging from $9.73 to $9.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:38 UTC | ZYNGA INC ZNGA · Entity 126967 | SaleClass A Common Stock | 17,900 | $9.00 | $161,100.00 |
DisclosureSEC source: 0001209191-20-064197 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,219 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted on 08/16/2020. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059996 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,438 Underlying: Class A Common Stock · 6,219 shares Expires 2027-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 17:11 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 6,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059996 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 16:59 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 6,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047756 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,657 Underlying: Class A Common Stock · 6,218 shares Expires 2027-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 16:59 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 6,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047756 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| May 19, 2020 Filed May 21, 2020 17:12 UTC | ZYNGA INC ZNGA · Entity 126967 | GrantRestricted Stock Unit · Derivative | 24,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031364 · doc4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,875 Underlying: Class A Common Stock · 24,875 shares Expires 2027-05-19 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 19, 2020, November 19, 2020, and February 19, 2021, and 25% of the restricted stock units vest on the earlier of May 19, 2021 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 07, 2020 Filed May 8, 2020 17:36 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028014 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,210 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
| May 07, 2020 Filed May 8, 2020 17:36 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionClass A Common Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028014 · doc4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 19:06 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 1,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006575 · form4.xml · derivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,225 Underlying: Common Stock · 1,225 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:26 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006188 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of February 15, 2020, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:26 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006188 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionDeferred Stock Units · Derivative | 1,990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005158 · form4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of VAR common stock. F1 · price: Each deferred stock unit represents the right to receive one share of VAR common stock. F2 · derivative.exercise_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. F2 · derivative.expiration_date: The Deferred Stock Units vest in four equal quarterly installments over a 12 month period beginning February 10, 2017. Vested shares will be delivered to the reporting person on the earlier of three years from the grant date, termination/retirement date, or a change in control. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:05 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-005158 · form4.xml · nonDerivative · entry 1 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the right to receive one share of VAR common stock. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 16:03 UTC | ZYNGA INC ZNGA · Entity 126967 | Exercise / conversionRestricted Stock Unit · Derivative | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-008267 · doc4.xml · derivative · entry 2 DUGAN REGINA E · CIK 0001593861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,210 Underlying: Class A Common Stock · 8,210 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon vest. F2 · derivative.exercise_date: Vests as follows: 25% of the restricted stock units vest on each of August 7, 2019, November 7, 2019, and February 7, 2020, and 25% of the restricted stock units vest on the earlier of May 7, 2020 or the date of the Issuer's next annual meeting, subject to continued service to the Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.